Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Recruiting · NCT06088030 · Registry updated 2024-01-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Li-Fraumeni syndrome, Nutritional and Metabolic Diseases, childhood malignant neoplasm, hereditary disease, hereditary neoplastic syndrome, metabolic disease, neoplasm | Recruiting | Phase 2 | 2024-01-03 | NCT06088030 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
| Yang Li | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou | China | 67 |